Click for best price
Precision Cancer Tests Market Size, Share 2022
Precision cancer tests encompass imaging and in vitro diagnostic products and procedures that directly detect malignancies in patient samples or in the patients themselves.
This report contains market size and forecasts of Precision Cancer Tests in Global, including the following market information:
Global Precision Cancer Tests Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Precision Cancer Tests market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Imaging Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Precision Cancer Tests include Abbott, BD, Bio-Rad, Cynvenio Biosystems, Foundation Medicine, Genomic Health, Illumina, Myriad Genetics and NanoString Technologies, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Precision Cancer Tests companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Precision Cancer Tests Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Precision Cancer Tests Market Segment Percentages, by Type, 2021 (%)
Imaging
In Vitro Diagnostic
Others
Global Precision Cancer Tests Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Precision Cancer Tests Market Segment Percentages, by Application, 2021 (%)
Cancer Research Centers
Cancer Hospital
Surgical Centers
Clinics
Others
Global Precision Cancer Tests Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Precision Cancer Tests Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Precision Cancer Tests revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Precision Cancer Tests revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Abbott
BD
Bio-Rad
Cynvenio Biosystems
Foundation Medicine
Genomic Health
Illumina
Myriad Genetics
NanoString Technologies
QIAGEN
Randox Laboratories
Roche
Philips
Thermo Fisher Scientific
| Report Attributes |
Report Details |
| Report Title |
Precision Cancer Tests Market - Global Outlook and Forecast 2022-2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
67 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Precision Cancer Tests Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Precision Cancer Tests Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Precision Cancer Tests Overall Market Size
2.1 Global Precision Cancer Tests Market Size: 2021 VS 2028
2.2 Global Precision Cancer Tests Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Precision Cancer Tests Players in Global Market
3.2 Top Global Precision Cancer Tests Companies Ranked by Revenue
3.3 Global Precision Cancer Tests Revenue by Companies
3.4 Top 3 and Top 5 Precision Cancer Tests Companies in Global Market, by Revenue in 2021
3.5 Global Companies Precision Cancer Tests Product Type
3.6 Tier 1, Tier 2 and Tier 3 Precision Cancer Tests Players in Global Market
3.6.1 List of Global Tier 1 Precision Cancer Tests Companies
3.6.2 List of Global Tier 2 and Tier 3 Precision Cancer Tests Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Precision Cancer Tests Market Size Markets, 2021 & 2028
4.1.2 Imaging
4.1.3 In Vitro Diagnostic
4.1.4 Others
4.2 By Type - Global Precision Cancer Tests Revenue & Forecasts
4.2.1 By Type - Global Precision Cancer Tests Revenue, 2017-2022
4.2.2 By Type - Global Precision Cancer Tests Revenue, 2023-2028
4.2.3 By Type - Global Precision Cancer Tests Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Precision Cancer Tests Market Size, 2021 & 2028
5.1.2 Cancer Research Centers
5.1.3 Cancer Hospital
5.1.4 Surgical Centers
5.1.5 Clinics
5.1.6 Others
5.2 By Application - Global Precision Cancer Tests Revenue & Forecasts
5.2.1 By Application - Global Precision Cancer Tests Revenue, 2017-2022
5.2.2 By Application - Global Precision Cancer Tests Revenue, 2023-2028
5.2.3 By Application - Global Precision Cancer Tests Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Precision Cancer Tests Market Size, 2021 & 2028
6.2 By Region - Global Precision Cancer Tests Revenue & Forecasts
6.2.1 By Region - Global Precision Cancer Tests Revenue, 2017-2022
6.2.2 By Region - Global Precision Cancer Tests Revenue, 2023-2028
6.2.3 By Region - Global Precision Cancer Tests Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Precision Cancer Tests Revenue, 2017-2028
6.3.2 US Precision Cancer Tests Market Size, 2017-2028
6.3.3 Canada Precision Cancer Tests Market Size, 2017-2028
6.3.4 Mexico Precision Cancer Tests Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Precision Cancer Tests Revenue, 2017-2028
6.4.2 Germany Precision Cancer Tests Market Size, 2017-2028
6.4.3 France Precision Cancer Tests Market Size, 2017-2028
6.4.4 U.K. Precision Cancer Tests Market Size, 2017-2028
6.4.5 Italy Precision Cancer Tests Market Size, 2017-2028
6.4.6 Russia Precision Cancer Tests Market Size, 2017-2028
6.4.7 Nordic Countries Precision Cancer Tests Market Size, 2017-2028
6.4.8 Benelux Precision Cancer Tests Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Precision Cancer Tests Revenue, 2017-2028
6.5.2 China Precision Cancer Tests Market Size, 2017-2028
6.5.3 Japan Precision Cancer Tests Market Size, 2017-2028
6.5.4 South Korea Precision Cancer Tests Market Size, 2017-2028
6.5.5 Southeast Asia Precision Cancer Tests Market Size, 2017-2028
6.5.6 India Precision Cancer Tests Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Precision Cancer Tests Revenue, 2017-2028
6.6.2 Brazil Precision Cancer Tests Market Size, 2017-2028
6.6.3 Argentina Precision Cancer Tests Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Precision Cancer Tests Revenue, 2017-2028
6.7.2 Turkey Precision Cancer Tests Market Size, 2017-2028
6.7.3 Israel Precision Cancer Tests Market Size, 2017-2028
6.7.4 Saudi Arabia Precision Cancer Tests Market Size, 2017-2028
6.7.5 UAE Precision Cancer Tests Market Size, 2017-2028
7 Players Profiles
7.1 Abbott
7.1.1 Abbott Corporate Summary
7.1.2 Abbott Business Overview
7.1.3 Abbott Precision Cancer Tests Major Product Offerings
7.1.4 Abbott Precision Cancer Tests Revenue in Global Market (2017-2022)
7.1.5 Abbott Key News
7.2 BD
7.2.1 BD Corporate Summary
7.2.2 BD Business Overview
7.2.3 BD Precision Cancer Tests Major Product Offerings
7.2.4 BD Precision Cancer Tests Revenue in Global Market (2017-2022)
7.2.5 BD Key News
7.3 Bio-Rad
7.3.1 Bio-Rad Corporate Summary
7.3.2 Bio-Rad Business Overview
7.3.3 Bio-Rad Precision Cancer Tests Major Product Offerings
7.3.4 Bio-Rad Precision Cancer Tests Revenue in Global Market (2017-2022)
7.3.5 Bio-Rad Key News
7.4 Cynvenio Biosystems
7.4.1 Cynvenio Biosystems Corporate Summary
7.4.2 Cynvenio Biosystems Business Overview
7.4.3 Cynvenio Biosystems Precision Cancer Tests Major Product Offerings
7.4.4 Cynvenio Biosystems Precision Cancer Tests Revenue in Global Market (2017-2022)
7.4.5 Cynvenio Biosystems Key News
7.5 Foundation Medicine
7.5.1 Foundation Medicine Corporate Summary
7.5.2 Foundation Medicine Business Overview
7.5.3 Foundation Medicine Precision Cancer Tests Major Product Offerings
7.5.4 Foundation Medicine Precision Cancer Tests Revenue in Global Market (2017-2022)
7.5.5 Foundation Medicine Key News
7.6 Genomic Health
7.6.1 Genomic Health Corporate Summary
7.6.2 Genomic Health Business Overview
7.6.3 Genomic Health Precision Cancer Tests Major Product Offerings
7.6.4 Genomic Health Precision Cancer Tests Revenue in Global Market (2017-2022)
7.6.5 Genomic Health Key News
7.7 Illumina
7.7.1 Illumina Corporate Summary
7.7.2 Illumina Business Overview
7.7.3 Illumina Precision Cancer Tests Major Product Offerings
7.7.4 Illumina Precision Cancer Tests Revenue in Global Market (2017-2022)
7.7.5 Illumina Key News
7.8 Myriad Genetics
7.8.1 Myriad Genetics Corporate Summary
7.8.2 Myriad Genetics Business Overview
7.8.3 Myriad Genetics Precision Cancer Tests Major Product Offerings
7.8.4 Myriad Genetics Precision Cancer Tests Revenue in Global Market (2017-2022)
7.8.5 Myriad Genetics Key News
7.9 NanoString Technologies
7.9.1 NanoString Technologies Corporate Summary
7.9.2 NanoString Technologies Business Overview
7.9.3 NanoString Technologies Precision Cancer Tests Major Product Offerings
7.9.4 NanoString Technologies Precision Cancer Tests Revenue in Global Market (2017-2022)
7.9.5 NanoString Technologies Key News
7.10 QIAGEN
7.10.1 QIAGEN Corporate Summary
7.10.2 QIAGEN Business Overview
7.10.3 QIAGEN Precision Cancer Tests Major Product Offerings
7.10.4 QIAGEN Precision Cancer Tests Revenue in Global Market (2017-2022)
7.10.5 QIAGEN Key News
7.11 Randox Laboratories
7.11.1 Randox Laboratories Corporate Summary
7.11.2 Randox Laboratories Business Overview
7.11.3 Randox Laboratories Precision Cancer Tests Major Product Offerings
7.11.4 Randox Laboratories Precision Cancer Tests Revenue in Global Market (2017-2022)
7.11.5 Randox Laboratories Key News
7.12 Roche
7.12.1 Roche Corporate Summary
7.12.2 Roche Business Overview
7.12.3 Roche Precision Cancer Tests Major Product Offerings
7.12.4 Roche Precision Cancer Tests Revenue in Global Market (2017-2022)
7.12.5 Roche Key News
7.13 Philips
7.13.1 Philips Corporate Summary
7.13.2 Philips Business Overview
7.13.3 Philips Precision Cancer Tests Major Product Offerings
7.13.4 Philips Precision Cancer Tests Revenue in Global Market (2017-2022)
7.13.5 Philips Key News
7.14 Thermo Fisher Scientific
7.14.1 Thermo Fisher Scientific Corporate Summary
7.14.2 Thermo Fisher Scientific Business Overview
7.14.3 Thermo Fisher Scientific Precision Cancer Tests Major Product Offerings
7.14.4 Thermo Fisher Scientific Precision Cancer Tests Revenue in Global Market (2017-2022)
7.14.5 Thermo Fisher Scientific Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Precision Cancer Tests Market Opportunities & Trends in Global Market
Table 2. Precision Cancer Tests Market Drivers in Global Market
Table 3. Precision Cancer Tests Market Restraints in Global Market
Table 4. Key Players of Precision Cancer Tests in Global Market
Table 5. Top Precision Cancer Tests Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Precision Cancer Tests Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Precision Cancer Tests Revenue Share by Companies, 2017-2022
Table 8. Global Companies Precision Cancer Tests Product Type
Table 9. List of Global Tier 1 Precision Cancer Tests Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Precision Cancer Tests Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Precision Cancer Tests Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Precision Cancer Tests Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Precision Cancer Tests Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application ? Global Precision Cancer Tests Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Precision Cancer Tests Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Precision Cancer Tests Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region ? Global Precision Cancer Tests Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Precision Cancer Tests Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Precision Cancer Tests Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Precision Cancer Tests Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Precision Cancer Tests Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Precision Cancer Tests Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Precision Cancer Tests Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Precision Cancer Tests Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Precision Cancer Tests Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Precision Cancer Tests Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Precision Cancer Tests Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Precision Cancer Tests Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Precision Cancer Tests Revenue, (US$, Mn), 2023-2028
Table 30. Abbott Corporate Summary
Table 31. Abbott Precision Cancer Tests Product Offerings
Table 32. Abbott Precision Cancer Tests Revenue (US$, Mn), (2017-2022)
Table 33. BD Corporate Summary
Table 34. BD Precision Cancer Tests Product Offerings
Table 35. BD Precision Cancer Tests Revenue (US$, Mn), (2017-2022)
Table 36. Bio-Rad Corporate Summary
Table 37. Bio-Rad Precision Cancer Tests Product Offerings
Table 38. Bio-Rad Precision Cancer Tests Revenue (US$, Mn), (2017-2022)
Table 39. Cynvenio Biosystems Corporate Summary
Table 40. Cynvenio Biosystems Precision Cancer Tests Product Offerings
Table 41. Cynvenio Biosystems Precision Cancer Tests Revenue (US$, Mn), (2017-2022)
Table 42. Foundation Medicine Corporate Summary
Table 43. Foundation Medicine Precision Cancer Tests Product Offerings
Table 44. Foundation Medicine Precision Cancer Tests Revenue (US$, Mn), (2017-2022)
Table 45. Genomic Health Corporate Summary
Table 46. Genomic Health Precision Cancer Tests Product Offerings
Table 47. Genomic Health Precision Cancer Tests Revenue (US$, Mn), (2017-2022)
Table 48. Illumina Corporate Summary
Table 49. Illumina Precision Cancer Tests Product Offerings
Table 50. Illumina Precision Cancer Tests Revenue (US$, Mn), (2017-2022)
Table 51. Myriad Genetics Corporate Summary
Table 52. Myriad Genetics Precision Cancer Tests Product Offerings
Table 53. Myriad Genetics Precision Cancer Tests Revenue (US$, Mn), (2017-2022)
Table 54. NanoString Technologies Corporate Summary
Table 55. NanoString Technologies Precision Cancer Tests Product Offerings
Table 56. NanoString Technologies Precision Cancer Tests Revenue (US$, Mn), (2017-2022)
Table 57. QIAGEN Corporate Summary
Table 58. QIAGEN Precision Cancer Tests Product Offerings
Table 59. QIAGEN Precision Cancer Tests Revenue (US$, Mn), (2017-2022)
Table 60. Randox Laboratories Corporate Summary
Table 61. Randox Laboratories Precision Cancer Tests Product Offerings
Table 62. Randox Laboratories Precision Cancer Tests Revenue (US$, Mn), (2017-2022)
Table 63. Roche Corporate Summary
Table 64. Roche Precision Cancer Tests Product Offerings
Table 65. Roche Precision Cancer Tests Revenue (US$, Mn), (2017-2022)
Table 66. Philips Corporate Summary
Table 67. Philips Precision Cancer Tests Product Offerings
Table 68. Philips Precision Cancer Tests Revenue (US$, Mn), (2017-2022)
Table 69. Thermo Fisher Scientific Corporate Summary
Table 70. Thermo Fisher Scientific Precision Cancer Tests Product Offerings
Table 71. Thermo Fisher Scientific Precision Cancer Tests Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Precision Cancer Tests Segment by Type in 2021
Figure 2. Precision Cancer Tests Segment by Application in 2021
Figure 3. Global Precision Cancer Tests Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Precision Cancer Tests Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Precision Cancer Tests Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Precision Cancer Tests Revenue in 2021
Figure 8. By Type - Global Precision Cancer Tests Revenue Market Share, 2017-2028
Figure 9. By Application - Global Precision Cancer Tests Revenue Market Share, 2017-2028
Figure 10. By Region - Global Precision Cancer Tests Revenue Market Share, 2017-2028
Figure 11. By Country - North America Precision Cancer Tests Revenue Market Share, 2017-2028
Figure 12. US Precision Cancer Tests Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Precision Cancer Tests Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Precision Cancer Tests Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Precision Cancer Tests Revenue Market Share, 2017-2028
Figure 16. Germany Precision Cancer Tests Revenue, (US$, Mn), 2017-2028
Figure 17. France Precision Cancer Tests Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Precision Cancer Tests Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Precision Cancer Tests Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Precision Cancer Tests Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Precision Cancer Tests Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Precision Cancer Tests Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Precision Cancer Tests Revenue Market Share, 2017-2028
Figure 24. China Precision Cancer Tests Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Precision Cancer Tests Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Precision Cancer Tests Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Precision Cancer Tests Revenue, (US$, Mn), 2017-2028
Figure 28. India Precision Cancer Tests Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Precision Cancer Tests Revenue Market Share, 2017-2028
Figure 30. Brazil Precision Cancer Tests Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Precision Cancer Tests Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Precision Cancer Tests Revenue Market Share, 2017-2028
Figure 33. Turkey Precision Cancer Tests Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Precision Cancer Tests Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Precision Cancer Tests Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Precision Cancer Tests Revenue, (US$, Mn), 2017-2028
Figure 37. Abbott Precision Cancer Tests Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. BD Precision Cancer Tests Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Bio-Rad Precision Cancer Tests Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Cynvenio Biosystems Precision Cancer Tests Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Foundation Medicine Precision Cancer Tests Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Genomic Health Precision Cancer Tests Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Illumina Precision Cancer Tests Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Myriad Genetics Precision Cancer Tests Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. NanoString Technologies Precision Cancer Tests Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. QIAGEN Precision Cancer Tests Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Randox Laboratories Precision Cancer Tests Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Roche Precision Cancer Tests Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. Philips Precision Cancer Tests Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. Thermo Fisher Scientific Precision Cancer Tests Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
